Hemostatic effects of aprotinin, tranexamic acid and ϵ-aminocaproic acid in primary cardiac surgery
- 1 December 1999
- journal article
- clinical trial
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 68 (6) , 2252-2256
- https://doi.org/10.1016/s0003-4975(99)00866-8
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Tranexamic Acid and Aprotinin Reduce Postoperative Bleeding and Transfusions During Primary Coronary RevascularizationAnesthesia & Analgesia, 1998
- High-Dose ϵ-Aminocaproic Acid Versus Aprotinin: Antifibrinolytic Efficacy in First-Time Coronary OperationsThe Annals of Thoracic Surgery, 1998
- Prophylactic Tranexamic Acid and ϵ-Aminocaproic Acid for Primary Myocardial RevascularizationThe Annals of Thoracic Surgery, 1998
- Drugs to Minimize Perioperative Blood Loss in Cardiac SurgeryAnesthesia & Analgesia, 1997
- Reduction of bleeding after heart operations through the prophylactic use of epsilon-aminocaproic acidThe Journal of Thoracic and Cardiovascular Surgery, 1996
- Reexploration for bleeding is a risk factor for adverse outcomes after cardiac operationsThe Journal of Thoracic and Cardiovascular Surgery, 1996
- AprotininDrugs, 1995
- Metaanalysis of prophylactic drug treatment in the prevention of postoperative bleedingThe Annals of Thoracic Surgery, 1994
- EFFECT OF APROTININ ON NEED FOR BLOOD TRANSFUSION AFTER REPEAT OPEN-HEART SURGERYThe Lancet, 1987
- Clinical Application of Inhibitors of FibrinolysisDrugs, 1985